S&P 500 Cons Disc Sector SPDR (XLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | XLY | NVO | JNJ | ||
| Company | S&P 500 Cons Disc Sector SPDR | Novo Nordisk A/S ADR | Johnson & Johnson | ||
| Price Information | |||||
| Exchange | NYSE Arca | NYSE | NYSE | ||
| Open | 215.62 | 103.91 | 155.90 | ||
| High | 218.73 | 106.24 | 157.12 | ||
| Low | 215.62 | 103.86 | 154.11 | ||
| Last | 218.10 | 105.06 | 155.17 | ||
| Change | +3.10 | +2.43 | -0.33 | ||
| % Change | +1.44% | +2.37% | -0.21% | ||
| Volume | 2,275,300 | 6,143,300 | 8,265,900 | ||
| 20-Day Average Volume | 3,104,855 | 6,818,175 | 7,503,385 | ||
| Previous Close | 215.00 | 102.63 | 155.50 | ||
| Industry | Finance - Investment Funds | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 209.96 | 107.35 | 156.37 | ||
| 20-Day Raw Stochastic | 90.30% | 39.33% | 38.65% | ||
| 20-Day Relative Strength | 66.06% | 39.62% | 43.01% | ||
| Weighted Alpha | +33.92 | -11.16 | +0.57 | ||
| Today's Opinion | 100% Buy | 100% Sell | 24% Sell | ||
| Previous Opinion | 100% Buy | 100% Sell | 24% Sell | ||
| Last Month's Opinion | 100% Buy | 88% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.18% since 11/15/24 | +3.26% since 11/15/24 | +0.76% since 11/15/24 | ||
| Low | 212.38 on 11/20/24 | 99.42 on 11/18/24 | 151.81 on 11/20/24 | ||
| High | 218.73 on 11/22/24 | 106.24 on 11/22/24 | 157.12 on 11/22/24 | ||
| 1-Month | |||||
| %Chg | +10.62% since 10/22/24 | -9.80% since 10/22/24 | -5.07% since 10/22/24 | ||
| Low | 193.03 on 10/23/24 | 99.42 on 11/18/24 | 150.76 on 11/14/24 | ||
| High | 220.39 on 11/11/24 | 116.43 on 10/23/24 | 166.00 on 10/23/24 | ||
| 3-Month | |||||
| %Chg | +18.33% since 08/22/24 | -23.25% since 08/22/24 | -4.42% since 08/22/24 | ||
| Low | 182.32 on 09/06/24 | 99.42 on 11/18/24 | 150.76 on 11/14/24 | ||
| High | 220.39 on 11/11/24 | 139.74 on 08/30/24 | 168.85 on 09/04/24 | ||
| 6-Month | |||||
| %Chg | +23.46% since 05/22/24 | -21.61% since 05/22/24 | +1.09% since 05/22/24 | ||
| Low | 166.48 on 08/05/24 | 99.42 on 11/18/24 | 143.71 on 05/29/24 | ||
| High | 220.39 on 11/11/24 | 148.15 on 06/25/24 | 168.85 on 09/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 22,381,106 | 471,460,128 | 373,590,880 | ||
| Shares Outstanding, K | 104,103 | 4,487,532 | 2,407,623 | ||
| Annual Sales | 0 | 33,724,300,000 | 85,159,000,000 | ||
| Annual Net Income | 0 | 12,150,770,000 | 35,153,000,000 | ||
| Last Quarter Sales | N/A | 10,511,240,000 | 22,471,000,000 | ||
| Last Quarter Net Income | N/A | 4,024,170,000 | 2,694,000,000 | ||
| 60-Month Beta | 1.18 | 0.42 | 0.53 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.90 on 11/06/24 | 2.42 on 10/15/24 | ||
| Latest Earnings Date | N/A | 11/06/24 | 10/15/24 | ||
| Most Recent Dividend | 0.405 on 09/23/24 | 0.362 on 08/16/24 | 1.240 on 11/26/24 | ||
| Next Ex-Dividends Date | 09/23/24 | 08/16/24 | 11/26/24 | ||
| Ratios | |||||
| Price/Earnings ttm | 24.20 | 33.21 | 15.19 | ||